Option Care Health (NASDAQ:OPCH) Issues Earnings Results

Option Care Health (NASDAQ:OPCH) announced its quarterly earnings data on Tuesday. The company reported $0.36 EPS for the quarter, meeting the consensus estimate of $0.36, Zacks reports. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. Option Care Health updated its FY 2025 guidance to 1.610-1.700 EPS.

Option Care Health Trading Down 0.5 %

NASDAQ:OPCH opened at $32.80 on Tuesday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The business’s 50 day moving average is $33.37 and its two-hundred day moving average is $28.78. Option Care Health has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a market cap of $5.39 billion, a PE ratio of 27.56, a P/E/G ratio of 2.30 and a beta of 1.07.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on OPCH shares. JPMorgan Chase & Co. increased their target price on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and lifted their price target for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price objective for the company from $26.00 to $33.00 in a research note on Monday, January 13th. JMP Securities reissued a “market outperform” rating and issued a $36.00 price objective on shares of Option Care Health in a report on Tuesday, April 22nd. Finally, Barrington Research reiterated an “outperform” rating and set a $38.00 price target on shares of Option Care Health in a report on Monday, April 21st. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $33.75.

Insider Buying and Selling at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.64% of the stock is currently owned by company insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.